BIOLASE, Inc.
BIOL · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $2,432 | $3,600 | $3,447 | $3,395 |
| - Cash | $3,444 | $5,272 | $6,393 | $6,566 |
| + Debt | $18,690 | $14,644 | $17,656 | $17,910 |
| Enterprise Value | $17,678 | $12,972 | $14,710 | $14,739 |
| Revenue | $10,850 | $11,555 | $10,131 | $13,490 |
| % Growth | -6.1% | 14.1% | -24.9% | – |
| Gross Profit | $4,382 | $4,609 | $3,336 | $3,524 |
| % Margin | 40.4% | 39.9% | 32.9% | 26.1% |
| EBITDA | -$166 | -$1,542 | -$5,184 | -$4,073 |
| % Margin | -1.5% | -13.3% | -51.2% | -30.2% |
| Net Income | -$1,428 | -$2,798 | -$6,485 | -$5,326 |
| % Margin | -13.2% | -24.2% | -64% | -39.5% |
| EPS Diluted | -0.04 | -0.084 | -0.36 | -1.76 |
| % Growth | 52.7% | 76.7% | 79.5% | – |
| Operating Cash Flow | -$4,472 | -$734 | -$5,938 | -$2,283 |
| Capital Expenditures | -$40 | -$27 | $27 | -$185 |
| Free Cash Flow | -$4,512 | -$761 | -$5,911 | -$2,468 |